169 related articles for article (PubMed ID: 11299739)
1. Correlation of immunohistochemical p53 labeling index with inhibition rate in chemosensitivity test in gastric and colon cancer.
Hosaka N; Ichikawa Y; Ishikawa T; Nagashima Y; Kunisaki C; Takahashi M; Moriwaki Y; Akiyama H; Yamaguchi S; Ota M; Ooki S; Ike H; Shimada H
Anticancer Res; 2001; 21(1A):229-35. PubMed ID: 11299739
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry of p53, Bcl-2, and Ki-67 as predictors of chemosensitivity.
Itaya M; Yoshimoto J; Kojima K; Kawasaki S
Methods Mol Med; 2005; 110():213-27. PubMed ID: 15901938
[TBL] [Abstract][Full Text] [Related]
3. [Anti-tumor effect of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with Bcl-2 expression].
Geng M; Yin YC; Cao YC; Fu ZJ; Tai YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 May; 11(3):276-9. PubMed ID: 18478476
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of p53 protein, Bcl-2 protein and Ki-67 as predictors of chemosensitivity of malignant tumors.
Itaya M; Yoshimoto J; Kojima K; Futagawa S
Oncol Rep; 1999; 6(3):675-82. PubMed ID: 10203614
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies of in vitro chemosensitivity test evaluated by ATP assay of gastrointestinal cancer].
Jinushi K; Hirabayashi N; Kirihara Y; Takagami S; Ryuji K; Yorishima T; Nishiyama M; Noso Y; Toge T
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2235-9. PubMed ID: 2122811
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
[TBL] [Abstract][Full Text] [Related]
7. [Relation between p53 expression of human colon cancer cell lines and induction of apoptosis by anticancer drugs].
Matsuhashi N; Matsuo A; Kawaguchi Y; Sugiyama Y; Saji S
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1855-8. PubMed ID: 14619538
[TBL] [Abstract][Full Text] [Related]
8. Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway.
Jiang XH; Lam SK; Lin MC; Jiang SH; Kung HF; Slosberg ED; Soh JW; Weinstein IB; Wong BC
Oncogene; 2002 Sep; 21(39):6113-22. PubMed ID: 12203123
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
10. p53 dependence and apoptosis in response to FP treatment with p53-transfected colon cancer cell lines by use of thin layer collagen gel.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Oncol Rep; 2004 Aug; 12(2):357-61. PubMed ID: 15254702
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of p27 protein in human breast cancer correlates with in vitro resistance to doxorubicin and mitomycin C.
Yang Q; Sakurai T; Yoshimura G; Takashi Y; Suzuma T; Tamaki T; Umemura T; Nakamura Y; Nakamura M; Utsunomiya H; Mori I; Kakudo K
Anticancer Res; 2000; 20(6B):4319-22. PubMed ID: 11205265
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
13. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status.
Al-Ayyoubi S; Gali-Muhtasib H
Mol Carcinog; 2007 Mar; 46(3):176-86. PubMed ID: 17192871
[TBL] [Abstract][Full Text] [Related]
14. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas.
Taguchi T; Kato Y; Baba Y; Nishimura G; Tanigaki Y; Horiuchi C; Mochimatsu I; Tsukuda M
Oncol Rep; 2004 Feb; 11(2):421-6. PubMed ID: 14719078
[TBL] [Abstract][Full Text] [Related]
15. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
16. [Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
Geng M; Yin YC; Cao YC; Fu ZJ; Wang XY; Tai YH
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):838-41. PubMed ID: 18396642
[TBL] [Abstract][Full Text] [Related]
17. [Association between p53 expression and chemosensitivity in advanced and recurrent gastric cancer].
Nakata B; Chung YS; Ogawa M; Maeda K; Inoue T; Yamashita Y; Sowa M
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():151-3. PubMed ID: 8678559
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical effects by preoperative oral low-dose tegafur administration in human gastric carcinomas: enhanced apoptosis and increased intratumoral microvessel density.
Goto E; Okamoto E; Adachi H; Fukuda Y; Ito H
Oncol Rep; 2002; 9(5):1021-6. PubMed ID: 12168067
[TBL] [Abstract][Full Text] [Related]
19. p53, bcl-2 and thymidine phosphorylase as predictive markers of chemotherapy in patients with advanced and recurrent gastric cancer.
Kikuyama S; Inada T; Shimizu K; Miyakita M; Ogata Y
Anticancer Res; 2001; 21(3C):2149-53. PubMed ID: 11501839
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation between P53 expression, BCL-2 expression, apoptosis and ex vivo chemosensitivity in advanced human breast cancer.
Rein DT; Schöndorf T; Breidenbach M; Janát MM; Weikelt A; Göhring UJ; Becker M; Mallmann P; Kurbacher CM
Anticancer Res; 2000; 20(6D):5069-72. PubMed ID: 11326670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
